What We Do Leadership Therapeutic Areas Partnering News Contact
M8 Pharmaceuticals Announces approval of Mokbio® PS128™ in Mexico
May 5th 2022
M8 Pharmaceuticals announces that its Mexican Affiliate has obtained COFEPRIS approval of MOKBIO® the first psychobiotic L. plantarum PS128™ in Mexico. MOKBIO® capsules is the first M8 original product approved in Mexico, a probiotic strain with support and studies to address the needs of patients with central nervous system disorders. These include MOKBIO® PS128's potential neurological and mental health benefits, such as improving sleep and reducing symptoms like those seen in those patients suffering from anxiety, depression, autism, and Parkinson's disease.
The product has been launched in several European countries and North America. M8 expects to bring the benefits of a new range of psychobiotics to Latin American patients, starting with Mexico. Psychobiotics are probiotics that can yield specific benefits to the nervous system. By modulating the gut-brain axis, MOKBIO® PS128™ has been shown to adjust levels of neurotransmitters, such as dopamine and serotonin. Products that contain these clinically proven strains are formulated to improve mental health and neurological conditions in children and adults.
For more information please contact:
Joel Barlan
Chief Executive Officer
T: +52 (55) 4431 2933
us.wm@moksha8.com
Rafael Ferrer
Vice President of Corporate Development
T: +1 (305) 299 6998
Rafael.ferrer@moksha8.com
MORE NEWS
M8 Pharmaceuticals Announces approval of Mokbio® PS128™ in Mexico
Pharmanovia expands strategic collaboration with M8 Pharmaceuticals in Latin America
M8 Pharmaceuticals and UCB partner for Central Nervous System and Respiratory Portfolio in Mexico.
Bened Biomedical Grants Exclusive Rights for PS128™ to M8 Pharmaceuticals
M8 Pharmaceuticals announces strategic partnership with Janssen for selected CNS Portfolio in Mexico
COPYRIGHT © 2006-2021 MOKSHA8 PHARMACEUTICALS, INC. ALL RIGHTS RESERVED. THIS INFORMATION—INCLUDING PRODUCT INFORMATION—IS INTENDED ONLY FOR RESIDENTS OF THE UNITED STATES. THE PRODUCTS DISCUSSED HEREIN MAY HAVE DIFFERENT LABELING IN DIFFERENT COUNTRIES.
PRIVACY POLICY | LEGAL DISCLAIMER | LINKEDIN | ENGLISH | PORTUGUESE | SPANISH
What We Do
About Us
Leadership
Partnering
News
COPYRIGHT © 2006-2019 MOKSHA8 PHARMACEUTICALS, INC. ALL RIGHTS RESERVED. This information—including product information—is intended only for residents of the united states. The products discussed herein may have different labeling in different countries.
PRIVACY POLICY | LEGAL DISCLAIMER
LINKEDIN | ENGLISH | PORTUGUESE
What We Do
About Us
Leadership
Partnering
News
COPYRIGHT © 2006-2019 MOKSHA8 PHARMACEUTICALS, INC. ALL RIGHTS RESERVED. This information—including product information—is intended only for residents of the united states. The products discussed herein may have different labeling in different countries.
PRIVACY POLICY | LEGAL DISCLAIMER
LINKEDIN | ENGLISH | PORTUGUESE
What We Do
Leadership
Partnering
COPYRIGHT © 2006-2021MOKSHA8 PHARMACEUTICALS, INC. ALL RIGHTS RESERVED. This information—including product information—is intended only for residents of the united states. The products discussed herein may have different labeling in different countries.
PRIVACY POLICY | LEGAL DISCLAIMER
LINKEDIN | ENGLISH | PORTUGUESE | SPANISH